MENU
NBIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurocrine Biosciences (NBIX) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

NBIX is expected to report earnings to fall 12.71% to $1.58 per share on February 11

Neurocrine Biosciences NBIX Stock Earnings Reports
Q4'24
Est.
$1.58
Q3'24
Beat
by $0.29
Q2'24
Beat
by $0.50
Q1'24
Beat
by $0.13
Q4'23
Beat
by $0.33
The last earnings report on October 30 showed earnings per share of $1.81, beating the estimate of $1.52. With 181.99K shares outstanding, the current market capitalization sits at 13.72B.
View a ticker or compare two or three
NBIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com